ArticleMolecular and clinical oncology2016

Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer.

Takayoshi Kiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.